Page last updated: 2024-10-25

citalopram and Heart Disease, Ischemic

citalopram has been researched along with Heart Disease, Ischemic in 12 studies

Citalopram: A furancarbonitrile that is one of the serotonin uptake inhibitors used as an antidepressant. The drug is also effective in reducing ethanol uptake in alcoholics and is used in depressed patients who also suffer from TARDIVE DYSKINESIA in preference to tricyclic antidepressants, which aggravate dyskinesia.
citalopram : A racemate comprising equimolar amounts of (R)-citalopram and its enantiomer, escitalopram. It is used as an antidepressant, although only escitalopram is active.
1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile : A nitrile that is 1,3-dihydro-2-benzofuran-5-carbonitrile in which one of the hydrogens at position 1 is replaced by a p-fluorophenyl group, while the other is replaced by a 3-(dimethylamino)propyl group.

Research Excerpts

ExcerptRelevanceReference
"The REMIT (Responses of Mental Stress Induced Myocardial Ischemia to Escitalopram Treatment) study, a randomized, double-blind, placebo-controlled trial of patients with clinically stable coronary heart disease and laboratory-diagnosed MSIMI."9.17Effect of escitalopram on mental stress-induced myocardial ischemia: results of the REMIT trial. ( Becker, RC; Boyle, SH; Jiang, W; Kuchibhatla, M; Kuhn, C; O'Connor, C; Ortel, TL; Rogers, JG; Samad, Z; Velazquez, EJ; Williams, RB, 2013)
"Patients with stable IHD enrolled in the REMIT (Responses of Mental Stress-Induced Myocardial Ischemia to Escitalopram) study underwent psychometric assessments, transthoracic echocardiography, and platelet aggregation studies at baseline and after 3 mental stress tasks."5.19Sex differences in platelet reactivity and cardiovascular and psychological response to mental stress in patients with stable ischemic heart disease: insights from the REMIT study. ( Becker, RC; Boyle, S; Ersboll, M; Jiang, W; Kuhn, C; O'Connor, CM; Ortel, TL; Rogers, JG; Samad, Z; Velazquez, EJ; Vora, AN; Williams, R; Zhang, Y, 2014)
"The REMIT (Responses of Mental Stress Induced Myocardial Ischemia to Escitalopram Treatment) study, a randomized, double-blind, placebo-controlled trial of patients with clinically stable coronary heart disease and laboratory-diagnosed MSIMI."5.17Effect of escitalopram on mental stress-induced myocardial ischemia: results of the REMIT trial. ( Becker, RC; Boyle, SH; Jiang, W; Kuchibhatla, M; Kuhn, C; O'Connor, C; Ortel, TL; Rogers, JG; Samad, Z; Velazquez, EJ; Williams, RB, 2013)
"Conclusion In patients with stable ischemic heart disease, mental, but not exercise, stress-induced left ventricular ejection fraction change significantly predicts risk of future adverse cardiovascular events."2.84Mental stress-induced left ventricular dysfunction and adverse outcome in ischemic heart disease patients. ( Babyak, MA; Becker, RC; Boyle, SH; Jiang, W; Kuhn, C; O'Connor, CM; Ortel, TL; Rogers, JG; Samad, Z; Sun, JL; Velazquez, EJ; Williams, RB; Wilson, JL, 2017)
"Sertraline is a reasonable first-line choice in patients with IHD and depression, whereas the role of citalopram as the first-line agent should be reconsidered."2.61Efficacy and acceptability of antidepressants in patients with ischemic heart disease: systematic review and meta-analysis. ( Barbui, C; Caruso, R; Gastaldon, C; Grassi, L; Hotopf, M; Ostuzzi, G; Papola, D; Rayner, L; Turrini, G, 2019)

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (8.33)29.6817
2010's11 (91.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ostuzzi, G1
Turrini, G1
Gastaldon, C1
Papola, D1
Rayner, L1
Caruso, R1
Grassi, L1
Hotopf, M1
Barbui, C1
Jiang, W5
Velazquez, EJ5
Kuchibhatla, M1
Samad, Z4
Boyle, SH3
Kuhn, C4
Becker, RC4
Ortel, TL4
Williams, RB3
Rogers, JG3
O'Connor, C1
Lim, GB1
Burg, MM1
Soufer, R1
Shiyovich, A1
O'Connor, CM4
Al Mheid, I1
Quyyumi, AA1
Boyle, S1
Ersboll, M1
Vora, AN1
Zhang, Y1
Williams, R1
Harrison, RW1
Wilson, J1
Tolentino, JC1
Schmidt, JJ1
Schmidt, GJ1
Mesquita, CT1
Schmidt, SL1
Sun, JL1
Babyak, MA1
Wilson, JL1
Pogosova, GV1
Koltunov, IE1
Karpova, AV1
Eliseeva, NA1
Sapunova, ID1

Clinical Trials (2)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Responses of Myocardial Ischemia to Escitalopram Treatment (REMIT Trial)[NCT00574847]Phase 4127 participants (Actual)Interventional2006-09-30Completed
Effect of Acupressure on Pain, Anxiety and Vital Signs in Patients With Coronary Angiography: A Randomized Controlled Study[NCT05082506]105 participants (Anticipated)Interventional2021-12-15Not yet recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

5HTT, Serotonin Transporter Protein

End point values adjusted for baseline values age and sex. (NCT00574847)
Timeframe: week 6

Interventionfmol/mg (Mean)
Escitalopram139.7
Placebo160.4

Beck Depression Inventory

The Beck Depression Inventory II (BDI-II) is a 21 question, self-administered measure of depressive symptoms. Score range, 0 to 63 (higher score=greater severity of depressive symptoms). End point values adjusted for baseline values age and sex. (NCT00574847)
Timeframe: 6 week

Interventionunits on a scale (Mean)
Escitalopram7.4
Placebo7.0

Cook-Medley Hostility (Ho) Hostile Affect Sub-scale

hostile affect, 0 to 5 (higher score=greater levels of hostile affect). End point values adjusted for baseline values age and sex. (NCT00574847)
Timeframe: 6 weeks

Interventionunits on a scale (Mean)
Escitalopram1.6
Placebo1.8

Cook-Medley Hostility (Ho) Scale

Score ranges: hostility, 0 to 27 (higher score=greater levels of hostility)/ End point values adjusted for baseline values age and sex. (NCT00574847)
Timeframe: 6 weeks

Interventionunits on a scale (Mean)
Escitalopram9.9
Placebo10.3

Exercise Stressed-induced Myocardial Ischemia (ESIMI)

End point values adjusted for baseline values age and sex. (NCT00574847)
Timeframe: 6 week

Interventionpercentage of change (Number)
Escitalopram45.8
Placebo52.5

Mental Stress Induced Change in Heart Rate

"A standard 12-lead Electrocardiograph (ECG) will be recorded at 1-minute intervals during the last 3 minutes of each rest period, the 3 minutes of the mental stress testing, and during exercise testing. Heart rate will be determined from the ECGs.~Mental Stress Induced Change in heart rate will be calculated by taking the mean of the mental stress heart rate measurements minus the resting heart rate measurements. End point values adjusted for baseline values age and sex." (NCT00574847)
Timeframe: baseline, 6 weeks

Interventionbeats/minute (Mean)
Escitalopram6.34
Placebo9.1

Mental Stress Induced Change of Diastolic Blood Pressure

Blood pressure will be measured the last 3 minutes of the 20 minute calibration period (resting), every minute during the 3 minutes mental stress testing, the last 3 minutes of the 6 minute rest periods between mental stress testing, and every minute during and after the physical stress testing with an automatic oscillometric blood pressure monitor (Quinton Electronics). Mental Stress Induced Change of Diastolic Blood Pressure will be calculated by taking the mean of the mental stress Diastolic blood pressure measurements minus the resting Diastolic blood pressure. End point values adjusted for baseline values age and sex. (NCT00574847)
Timeframe: Baseline, week 6

Interventionmm Hg (Mean)
Escitalopram11.4
Placebo12.2

Mental Stress Induced Change of Systolic Blood Pressure

Blood pressure will be measured the last 3 minutes of the 20 minute calibration period (resting), every minute during the 3 minutes mental stress testing, the last 3 minutes of the 6 minute rest periods between mental stress testing, and every minute during and after the physical stress testing with an automatic oscillometric blood pressure monitor (Quinton Electronics). Mental Stress Induced Change of Systolic Blood Pressure will be calculated by taking the mean of the mental stress systolic blood pressure measurements minus the resting Systolic blood pressure. End point values adjusted for baseline values age and sex. (NCT00574847)
Timeframe: Baseline, week 6

Interventionmm Hg (Mean)
Escitalopram19.3
Placebo23.6

Perceived Stress Scale

Score range, 10 to 50 (higher score = greater levels of perceived stress). End point values adjusted for baseline values age and sex. (NCT00574847)
Timeframe: 6 weeks

Interventionunits on a scale (Mean)
Escitalopram21.4
Placebo21.8

Percentage of Participants With Adverse Events

(NCT00574847)
Timeframe: Baseline to week 6

Interventionpercentage of participants (Number)
Escitalopram71.9
Placebo44.4

Percentage of Participants With an Absence of Mental Stress-induced Myocardial Ischemia (MSIMI) During the 3 Mental Stressors

MSIMI is defined by the following: compared to rest, 1) any development of new abnormal wall motion; 2) reduction of LVEF 8% and/or; 3) deviation (depression or elevation) of ST-segment of ECG in 2 or more leads lasting for 3 consecutive beats, occurring during at least one of the 3 mental stress tasks. (NCT00574847)
Timeframe: Week 6

Interventionpercentage of participants (Number)
Escitalopram34.2
Placebo17.5

Percentage of Participants With Overall Mental Stress-induced Myocardial Ischemia (MSIMI)

MSIMI is defined by the following: compared to rest, 1) any development of new abnormal wall motion; 2) reduction of LVEF 8% and/or; 3) deviation (depression or elevation) of ST-segment of ECG in 2 or more leads lasting for 3 consecutive beats, occurring during at least one of the 3 mental stress tasks. (NCT00574847)
Timeframe: week 6

Interventionpercentage of participants (Number)
Escitalopram66.1
Placebo83.9

Platelet Serotonin Binding Affinity Kd_100

End point values adjusted for baseline values age and sex. (NCT00574847)
Timeframe: 6 weeks

InterventionnM (Mean)
Escitalopram4202.4
Placebo210.1

Spielberger State-Trait Anxiety Inventory Scales (STAI)

STAI measures anxiety. The questionnaire asks the patients how they feel and allows them to respond on a frequency scale that ranges from 1(not at all) to 4(almost always/very much so). Scores range from 20-80 and the higher the score the greater the anxiety level. This applies to both the Trait and State scales. End point values adjusted for baseline values age and sex. (NCT00574847)
Timeframe: 6 weeks

,
Interventionunits on a scale (Mean)
TraitState
Escitalopram31.227.9
Placebo32.029.5

Reviews

1 review available for citalopram and Heart Disease, Ischemic

ArticleYear
Efficacy and acceptability of antidepressants in patients with ischemic heart disease: systematic review and meta-analysis.
    International clinical psychopharmacology, 2019, Volume: 34, Issue:2

    Topics: Adult; Antidepressive Agents; Citalopram; Depression; Humans; Myocardial Ischemia; Quality of Life;

2019

Trials

5 trials available for citalopram and Heart Disease, Ischemic

ArticleYear
Effect of escitalopram on mental stress-induced myocardial ischemia: results of the REMIT trial.
    JAMA, 2013, May-22, Volume: 309, Issue:20

    Topics: Aged; Citalopram; Coronary Disease; Disease Progression; Double-Blind Method; Electrocardiography; E

2013
Sex differences in platelet reactivity and cardiovascular and psychological response to mental stress in patients with stable ischemic heart disease: insights from the REMIT study.
    Journal of the American College of Cardiology, 2014, Oct-21, Volume: 64, Issue:16

    Topics: Aged; Antidepressive Agents, Second-Generation; Blood Platelets; Citalopram; Double-Blind Method; Fe

2014
Platelet aggregation and mental stress induced myocardial ischemia: Results from the Responses of Myocardial Ischemia to Escitalopram Treatment (REMIT) study.
    American heart journal, 2015, Volume: 169, Issue:4

    Topics: Citalopram; Electrocardiography; Female; Humans; Male; Middle Aged; Myocardial Ischemia; Platelet Ag

2015
Mental stress-induced left ventricular dysfunction and adverse outcome in ischemic heart disease patients.
    European journal of preventive cardiology, 2017, Volume: 24, Issue:6

    Topics: Aged; Citalopram; Disease-Free Survival; Female; Humans; Male; Mental Health; Middle Aged; Multivari

2017
[Clinical efficacy of escitalopram in patients with ischemic heart disease and comorbid depression].
    Kardiologiia, 2009, Volume: 49, Issue:3

    Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Citalopram; Depression; Female; Humans; Male;

2009

Other Studies

6 other studies available for citalopram and Heart Disease, Ischemic

ArticleYear
Coronary artery disease: Antidepressant treatment for mental stress-induced myocardial ischaemia.
    Nature reviews. Cardiology, 2013, Volume: 10, Issue:8

    Topics: Citalopram; Coronary Disease; Female; Humans; Male; Myocardial Ischemia; Selective Serotonin Reuptak

2013
Therapy for mental stress-induced myocardial ischemia.
    JAMA, 2013, Oct-02, Volume: 310, Issue:13

    Topics: Citalopram; Coronary Disease; Female; Humans; Male; Myocardial Ischemia; Selective Serotonin Reuptak

2013
Therapy for mental stress-induced myocardial ischemia.
    JAMA, 2013, Oct-02, Volume: 310, Issue:13

    Topics: Citalopram; Coronary Disease; Female; Humans; Male; Myocardial Ischemia; Selective Serotonin Reuptak

2013
Therapy for mental stress-induced myocardial ischemia--reply.
    JAMA, 2013, Oct-02, Volume: 310, Issue:13

    Topics: Citalopram; Coronary Disease; Female; Humans; Male; Myocardial Ischemia; Selective Serotonin Reuptak

2013
Sex differences in mental stress-induced myocardial ischemia: are women from venus?
    Journal of the American College of Cardiology, 2014, Oct-21, Volume: 64, Issue:16

    Topics: Blood Platelets; Citalopram; Female; Humans; Male; Myocardial Ischemia; Platelet Activation; Sex Cha

2014
Mental Stress-Induced Myocardial Ischemia Related to Generalized Anxiety Disorder in a Patient With Acute Coronary Syndrome and Normal Coronary Arteries.
    Clinical nuclear medicine, 2016, Volume: 41, Issue:11

    Topics: Acute Coronary Syndrome; Anxiety Disorders; Citalopram; Computed Tomography Angiography; Coronary An

2016